Levetiracetam Stada

Levetiracetam, the active ingredient in Levetiracetam Stada, is an anticonvulsant presented as an oral dosage form for oral use. It is employed to treat partial, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug indicated for several seizure types.

Partial seizures: reduces the frequency of focal onset seizures. Generalized tonic‑clonic seizures: helps control convulsive episodes. Myoclonic seizures: diminishes rapid, brief muscle jerks associated with epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Headache: mild to moderate head pain. - Irritability: increased emotional sensitivity. - Nausea: upset stomach or urge to vomit. - Somnolence: excessive sleepiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, anxiety, or suicidal thoughts. - Hematologic abnormalities: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Stevens‑Johnson syndrome: severe skin blistering. - Multi‑organ hypersensitivity: systemic inflammatory response.

When prescribing Levetiracetam, clinicians should consider several safety aspects.

Renal impairment: adjust dose based on renal function. Pregnancy: evaluate risk‑benefit, as safety data are limited. Concomitant CNS depressants: monitor for additive sedation. Psychiatric history: watch for mood alterations. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenobarbital: can reduce seizure control. - Phenytoin: potential decrease in therapeutic effect.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Sedative antihistamines: increase drowsiness. - Other antiepileptics: monitor for additive side effects.